Finabase

    • Login
    • Categories
    Home Watchlists Portfolios Map Forex Futures Crypto Comparisons Alerts Screeners Backtests vTrading Settings Forum
    1. Home
    2. BCRX
    • Alert
    • Note
    BCRX
    BioCryst Pharmaceuticals, Inc.
    14.21
    -
    0.04
    0.25%
    5 x 14.21
    2 x 14.22
    bid
    ask
    10:50 AM
    timesize
    Bearish 29
    Bullish 78
    sentiment
    14.12
    day range
    14.37
    7.89
    52 week range
    19.76
    10:50 AM
    V: 404.60K
    C: 14.21
    L: 14.12
    H: 14.37
    O: 14.34
    loading chart ...
    • 1d
    • 5d
    • 1m
    • 3m
    • 6m
    • ytd
    • 1y
    • 2y
    • 5y
    • max
    • PDF
    • Full Chart
    • Stats
    • Watchlist
    • Portfolio
    Prev Close14.25
    Open14.34
    Low14.12
    High14.37
    Volume404.60K
    Avg. Volume3.10M
    Market Cap2.64B
    Inst. Own83.89%
    Beta2.20
    Short Ratio12.23
    Div & Yield0.00 /
    EPS-1.07
    P/E
    1yr Target18.60
    50day MA11.44
    200day MA12.90
    ^DJI
    Dow Jones Industrial Average
    33941.70
    10:49 AM
    -
    38.60
    0.11%
    ^IXIC
    NASDAQ Composite
    12957.50
    10:49 AM
    +
    19.40
    0.15%
    ^GSPC
    S&P 500
    4279.05
    10:49 AM
    +
    5.01
    0.12%
    AAPL
    Apple Inc.
    174.34
    10:50 AM
    5 x 174.33
    11 x 174.35
    -
    0.21
    0.12%
    GOOG
    Alphabet Inc.
    120.85
    10:50 AM
    9 x 120.36
    40 x 120.39
    +
    0.53
    0.44%
    AMZN
    Amazon.com, Inc.
    142.02
    10:50 AM
    1 x 142.02
    3 x 142.04
    -
    0.08
    0.06%
    MSFT
    Microsoft Corporation
    290.86
    10:50 AM
    13 x 289.89
    8 x 289.92
    -
    0.46
    0.16%
    BABA
    Alibaba Group Holding Limited
    90.59
    10:50 AM
    1 x 90.58
    1 x 90.60
    +
    0.82
    0.92%
    NFLX
    Netflix, Inc.
    243.21
    10:50 AM
    10 x 241.69
    9 x 241.68
    +
    2.06
    0.85%
    TSLA
    Tesla, Inc.
    917.67
    10:50 AM
    10 x 910.33
    14 x 910.54
    +
    5.68
    0.62%
    NVDA
    NVIDIA Corporation
    186.77
    10:50 AM
    11 x 184.45
    8 x 184.45
    +
    3.42
    1.86%
    AMD
    Advanced Micro Devices, Inc.
    99.33
    10:50 AM
    3 x 99.31
    9 x 99.33
    +
    1.06
    1.08%
    MU
    Micron Technology, Inc.
    62.82
    10:50 AM
    14 x 62.35
    9 x 62.22
    +
    1.20
    1.95%
    SPY
    SPDR S&P 500 ETF Trust
    427.34
    10:50 AM
    9 x 426.17
    8 x 426.16
    +
    0.69
    0.16%
    TQQQ
    ProShares UltraPro QQQ
    37.60
    10:50 AM
    11 x 37.08
    11 x 37.09
    +
    0.30
    0.82%
    BRK-A
    Berkshire Hathaway Inc.
    455082.00
    10:48 AM
    10 x 454095.00
    11 x 454425.00
    -
    2196.00
    0.48%
    Day Gain
    Gain
    Market Val
    Costs
    Cash
    Portfolio
    Realized
    Dividend
    • Summary
    • Discussion
    • News
    • Signals
    • Financials
    • Alerts
    • Notes
    • Chart
    • Backtest
    News ...
    2022-08-18 | NDAQ:BCRX | Press Release | BioCryst Pharmaceuticals Inc. stockhouse.com •
    Russell Investments Group Ltd. Has $1.31 Million Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) defenseworld.net •
    BioCryst Pharmaceuticals Inc (BCRX) Down 3.35% in Premarket Trading investorsobserver.com •
    Ginkgo Bioworks Holdings Inc (DNA) Down 3.48% in Premarket Trading investorsobserver.com •
    BioCryst Announces Approval of ORLADEYO® (berotralstat) in Saudi Arabia marketscreener.com •
    State Board of Administration of Florida Retirement System Sells 13040 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) defenseworld.net •
    Profile ...
    BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
    Earning ...
    Date For Estimate Reported Surprise surprise %
    2022-08-04 2022-06 -0.36 -0.32 0.04 11.11%
    2022-05-05 2022-03 -0.39 -0.4 -0.01 -2.56%
    2022-02-23 2021-12 -0.31 -0.4 -0.09 -29.03%
    2021-11-03 2021-09 -0.3 -0.33 -0.03 -10.00%
    2021-08-05 2021-06 -0.22 -0.24 -0.02 -9.09%
    2021-05-06 2021-03 -0.26 -0.36 -0.1 -38.46%
    Upgrade / Downgrade ...
    Date Firm Action From To
    2022-08-08 Oppenheimer Downgrade Outperform Perform
    2022-08-05 Barclays Upgrade Equal-Weight
    2022-08-05 Oppenheimer Downgrade Outperform Perform
    2022-08-05 Evercore ISI Group Downgrade Outperform In-Line
    2022-04-18 Barclays Downgrade Overweight Equal-Weight
    2022-04-12 RBC Capital Upgrade Sector Perform
    Insider Holder ...
    Date Name Relation Quantity Description
    2022-06-06 ABERCROMBIE GEORGE B Director 12.87K Stock Award(Grant)
    2022-06-06 ASELAGE STEPHEN J Director 46.59K Stock Award(Grant)
    2022-06-06 GALSON STEVEN K Director 12.87K Stock Award(Grant)
    2022-06-06 HEGGIE THERESA Director 30.23K Stock Award(Grant)
    2022-06-06 HUTSON NANCY J Director 77.94K Stock Award(Grant)
    2022-06-06 INGRAM ROBERT ALEXANDER Director 95.00K Stock Award(Grant)
    Institution Ownership ...
    Report Date Organization Position Value Percentage
    2022-06-29 Blackrock Inc. 13.99M 199.32M 7.52%
    2022-06-29 Vanguard Group, Inc. (The) 13.81M 196.79M 7.43%
    2022-03-30 Baker Brothers Advisors, LLC 12.71M 181.13M 6.84%
    2022-03-30 State Street Corporation 7.46M 106.34M 4.01%
    2022-06-29 Pictet Asset Management SA 6.05M 86.17M 3.25%
    2022-06-29 Fisher Asset Management, LLC 5.22M 74.34M 2.81%
    Fund Ownership ...
    Report Date Organization Position Value Percentage
    2022-06-29 SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF 7.26M 103.50M 3.91%
    2022-03-30 Vanguard Total Stock Market Index Fund 5.26M 74.97M 2.83%
    2022-06-29 iShares Russell 2000 ETF 4.17M 59.43M 2.25%
    2022-05-30 Fidelity Select Portfolios - Biotechnology 4.19M 59.74M 2.25%
    2022-04-29 Lord Abbett Developing Growth Fund 2.45M 34.94M 1.32%
    2022-03-30 Vanguard Extended Market Index Fund 2.39M 34.03M 1.29%
    Dividend ...
    Dividend Date
    0 2014-06-11
    0 2014-06-05
    0 2014-05-20
    0 2014-05-16
    0 2014-04-02
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • oriley.services
      oriley.services last edited by

      $BCRX Man O Manischewitz

      1 Reply Last reply Reply Quote 0
      • oriley.services
        oriley.services last edited by

        $BCRX Wish I was a rich man I’d be swinging from the trees ….but I’m not I’ll just keep buying and holding mabe someday

        1 Reply Last reply Reply Quote 0
        • oriley.services
          oriley.services last edited by

          $BCRX No US troops to Ukraine possibly 3-5k to other Eastern European countries let’s get it straight

          1 Reply Last reply Reply Quote 0
          • oriley.services
            oriley.services last edited by

            $BCRX What are we doing just gonna hand it too um I’m doing my part 100 at a time.

            1 Reply Last reply Reply Quote 0
            • oriley.services
              oriley.services last edited by

              $BCRX I get a kick out of this

              1 Reply Last reply Reply Quote 0
              • oriley.services
                oriley.services last edited by

                $BCRX @Bio99 Thank you for the DD this evening but more importantly thank you for all the research and knowledge you have shared over the past 18 months +- God bless and may the wind always be at your back my friend.

                1 Reply Last reply Reply Quote 0
                • oriley.services
                  oriley.services last edited by

                  $BCRX @STONEHOUSESCOFFEEMUG 🤙 Well done!

                  1 Reply Last reply Reply Quote 0
                  • oriley.services
                    oriley.services last edited by

                    $BCRX At least all my others are PINK that’s being positive

                    1 Reply Last reply Reply Quote 0
                    • oriley.services
                      oriley.services last edited by

                      $BCRX I you going to state a fact you need to get straight

                      1 Reply Last reply Reply Quote 0
                      • oriley.services
                        oriley.services last edited by

                        $BCRX Where is he

                        1 Reply Last reply Reply Quote 0
                        • oriley.services
                          oriley.services last edited by

                          $BCRX This is like having eye teeth pulled ouch ouch!

                          1 Reply Last reply Reply Quote 0
                          • oriley.services
                            oriley.services last edited by

                            $BCRX What is this went to the kitchen for a beer and came back and we dropped all the way to 15.80

                            1 Reply Last reply Reply Quote 0
                            • oriley.services
                              oriley.services last edited by

                              $BCRX I don’t think I can take 67 more of this

                              1 Reply Last reply Reply Quote 0
                              • oriley.services
                                oriley.services last edited by

                                $BCRX The only thing to say here is THANK YOU FROM THE BOTTOM OF MY HEART MR. STONEHOUSE.

                                1 Reply Last reply Reply Quote 0
                                • oriley.services
                                  oriley.services last edited by

                                  $BCRX @Beer Good switch to Blatz Beer it’s goood

                                  1 Reply Last reply Reply Quote 0
                                  • oriley.services
                                    oriley.services last edited by

                                    $BCRX That’s OK you can go back to sleep we can try it again tomorrow when you’ve had a little more rest

                                    1 Reply Last reply Reply Quote 0
                                    • oriley.services
                                      oriley.services last edited by

                                      $BCRX I know what it is it’s a short attack by those Gritonites led by you know who they have been planning this for several months

                                      1 Reply Last reply Reply Quote 0
                                      • oriley.services
                                        oriley.services last edited by

                                        $BCRX What a way to throw away 5 30 packs of Keystone Light

                                        1 Reply Last reply Reply Quote 0
                                        • oriley.services
                                          oriley.services last edited by

                                          $BCRX I guess taking profits is good but there is a much bigger pot of gold at the end of this Rainbow if u hold as the Village Idiot says “come on man”

                                          1 Reply Last reply Reply Quote 0
                                          • oriley.services
                                            oriley.services last edited by

                                            $BCRX Ain’t it so “If your going through hell, keep on going” Winston Churchill

                                            1 Reply Last reply Reply Quote 0
                                            • 1
                                            • 2
                                            • 3
                                            • 4
                                            • 5
                                            • 18
                                            • 19
                                            • 1 / 19
                                            • First post
                                              Last post
                                            • 2022-08-18 | NDAQ:BCRX | Press Release | BioCryst Pharmaceuticals Inc.
                                              stockhouse.com •

                                            • Russell Investments Group Ltd. Has $1.31 Million Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
                                              defenseworld.net •

                                            • BioCryst Pharmaceuticals Inc (BCRX) Down 3.35% in Premarket Trading
                                              investorsobserver.com •

                                            • Ginkgo Bioworks Holdings Inc (DNA) Down 3.48% in Premarket Trading
                                              investorsobserver.com •

                                            • BioCryst Announces Approval of ORLADEYO® (berotralstat) in Saudi Arabia
                                              marketscreener.com •

                                            • State Board of Administration of Florida Retirement System Sells 13040 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
                                              defenseworld.net •

                                            • BioCryst Pharmaceuticals, Inc. to Post Q3 2022 Earnings of ($0.07) Per Share, Jefferies Financial Group Forecasts (NASDAQ:BCRX)
                                              marketbeat.com •

                                            • Top 5 2nd Quarter Trades of Biondo Investment Advisors, LLC
                                              gurufocus.com •

                                            • Options Bulls Blast Phama Stock on Lifted Clinical Hold
                                              schaeffersresearch.com •

                                            • BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q2 Results - Earnings Call Transcript
                                              seekingalpha.com •

                                            • Why BioCryst Pharmaceuticals Stock Is Bolting Higher Today
                                              fool.com •

                                            • 3 Fast-Growing Stocks to Buy Now
                                              fool.com •

                                            • BioCryst to Report Second Quarter 2022 Financial Results on August 4
                                              globenewswire.com •

                                            • BioCryst to Present at Upcoming Investor Conference
                                              globenewswire.com •

                                            • BioCryst: A Prudent Diversification
                                              seekingalpha.com •

                                            • Strength Seen in BioCryst (BCRX): Can Its 5.5% Jump Turn into More Strength?
                                              zacks.com •

                                            • Why BioCryst Pharmaceuticals Topped the Market Today
                                              fool.com •

                                            • 7 Cheap Biotech Stocks to Buy Now
                                              investorplace.com •

                                            • BioCryst to Present at Upcoming Investor Conferences
                                              globenewswire.com •

                                            • Why BioCryst Stock Lost Nearly 4% of Its Value Today
                                              fool.com •

                                            • Why BioCryst Stock Shot Nearly 5% Higher Today
                                              fool.com •

                                            • BioCryst to Report First Quarter 2022 Financial Results on May 5
                                              globenewswire.com •

                                            • Why BioCryst Pharmaceuticals Stock Sank Today
                                              fool.com •

                                            • Why BioChryst Pharmaceuticals' Stock Jumped 14.7% This Week
                                              fool.com •

                                            • Strength Seen in BioCryst (BCRX): Can Its 15.2% Jump Turn into More Strength?
                                              zacks.com •

                                            • BioCryst (BCRX) Pauses Enrolment in Key Studies, Stock Down
                                              zacks.com •

                                            • Why BioCryst Pharmaceuticals Stock Is Falling
                                              benzinga.com •

                                            • BioCryst to Present at Upcoming Investor Conference
                                              globenewswire.com •

                                            • Read Here Why Did BioCryst Stopped Enrollment In BCX9930 Studies In Rare Blood Disorder
                                              benzinga.com •

                                            • Why BioCryst Pharmaceuticals Stock Is Plunging Today
                                              benzinga.com •

                                            • Why BioCryst Pharmaceuticals Stock Slid Today
                                              fool.com •

                                            • BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q4 2021 Results - Earnings Call Transcript
                                              seekingalpha.com •

                                            • BioCryst Pharmaceuticals (BCRX) Reports Q4 Loss, Misses Revenue Estimates
                                              zacks.com •

                                            • Is BioCryst (BCRX) Ready to Breakout to New Highs on Recent Catalysts?
                                              benzinga.com •

                                            • Updated Guidance And Royalty Pharma Financing Demolish Short Thesis For BioCryst Pharmaceuticals
                                              seekingalpha.com •

                                            • BioCryst to Present New ORLADEYO® (berotralstat) Data at 2022 American Academy of Allergy, Asthma & Immunology Annual Meeting
                                              globenewswire.com •

                                            • Why BioCryst Pharmaceuticals Stock Is Skyrocketing This Week
                                              fool.com •

                                            • BioCryst Pharmaceuticals Stock (BCRX): Why The Price Surged Today
                                              pulse2.com •

                                            • Why BioCryst Pharmaceuticals Stock Is Jumping on Monday
                                              fool.com •

                                            • BioCryst Provides Tremendous Option Value
                                              seekingalpha.com •

                                            • BioCryst: Great Execution, Impressive Pipeline, Long Cash Runway
                                              seekingalpha.com •

                                            • BioCryst (BCRX) Begins Enrollment in PNH Study on BCX9930
                                              zacks.com •

                                            • BioCryst Shares Gain As Royalty Pharma Buys Additional Interests In BCX9930, Orladeyo
                                              benzinga.com •

                                            • 7 Top Growth Stocks to Buy as We Step Into November
                                              investorplace.com •

                                            • BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q3 2021 Results - Earnings Call Transcript
                                              seekingalpha.com •

                                            • Here's Why BioCryst Pharmaceuticals Stock Is Losing Ground Today
                                              fool.com •

                                            • BioCryst to Present New ORLADEYO® (berotralstat) Data at Annual Scientific Meeting of American College of Allergy, Asthma & Immunology
                                              globenewswire.com •

                                            • BioCryst to Report Third Quarter 2021 Financial Results on November 3
                                              globenewswire.com •

                                            • 7 Best Growth Stocks to Buy and Hold for the Next 10 Years
                                              investorplace.com •

                                            • 2 Super-Charged Growth Stocks to Buy Now
                                              fool.com •

                                            • BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
                                              globenewswire.com •

                                            • 3 Biotech Stocks Wall Street Thinks Could Rise 44% or Better
                                              fool.com •

                                            • NICE Recommends BioCryst's Hereditary Angioedema Med
                                              benzinga.com •

                                            • NICE Recommends BioCryst's ORLADEYO® (berotralstat), the First Oral, Once-daily Therapy, to Prevent Attacks in HAE Patients in the UK
                                              globenewswire.com •

                                            • What Wall Street Still Has Wrong. BioCryst To Become Next Rare Disease Giant
                                              seekingalpha.com •

                                            • BioCryst to Present at Upcoming Investor Conferences
                                              globenewswire.com •

                                            • BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
                                              globenewswire.com •

                                            • US Government Exercises Option To Buy Additional Doses Of BioCryst's Flu Med
                                              benzinga.com •

                                            • U.S. Government Exercises Option to Purchase Additional RAPIVAB® (peramivir injection) from BioCryst for Delivery to Strategic National Stockpile
                                              globenewswire.com •

                                            • BioCryst Appoints Dr. Steven Galson to Board of Directors
                                              globenewswire.com •

                                            • BioCryst Announces Acceptance of Regulatory Applications for ORLADEYO® (berotralstat) by Health Canada and Swissmedic
                                              globenewswire.com •

                                            • 2 Soaring Biotech Stocks With More Fuel in the Tank
                                              fool.com •

                                            • BioCryst Stock Jumps After Pulling Out $200M Equity Raise
                                              benzinga.com •

                                            • BioCryst Withdraws Public Offering
                                              globenewswire.com •

                                            • Why BioCryst Pharmaceuticals Rose 8% on Thursday
                                              fool.com •

                                            • BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q2 2021 Results - Earnings Call Transcript
                                              seekingalpha.com •

                                            • BioCryst Pharma Stock Heads Higher Thursday: Here's Why
                                              benzinga.com •

                                            • Tuesday Afternoon Analyst Upgrades and Downgrades: Exxon Mobil, First Solar, Tesla and More
                                              247wallst.com •

                                            • 3 Biotech Stocks That Could Rocket Higher
                                              fool.com •

                                            • BioCryst to Report Second Quarter 2021 Financial Results on August 5
                                              globenewswire.com •

                                            • BioCryst Pharmaceuticals - Orladeyo Revenue Will Drive Share Price
                                              seekingalpha.com •

                                            • BioCryst Outlines Pivotal Trial Designs For BCX9930 In Rare Blood Disorder
                                              benzinga.com •

                                            • BioCryst Shares 96-Week Orladeyo Data Highlighting 80% Reduction In HAE Attacks
                                              benzinga.com •

                                            • BioCryst Reports 96-week Data from APeX-2 Showing ORLADEYO®(berotralstat) Reduced HAE Attack Rate by 80 Percent from Baseline
                                              globenewswire.com •

                                            • ORLADEYO™ (berotralstat) Data to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress
                                              globenewswire.com •

                                            • Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
                                              seekingalpha.com •

                                            • Up 126% in 2021, Could BioCryst Pharmaceuticals Go Even Higher?
                                              fool.com •

                                            • BioCryst Announces Acceptance and Accelerated Review of the ORLADEYO™ (berotralstat) Marketing Application by the Israeli Ministry of Health
                                              globenewswire.com •

                                            • 7 A-Rated Biotech Stocks to Buy Now
                                              investorplace.com •

                                            • BioCryst Pharmaceuticals: An Orphan Disease Innovator With More Upside
                                              seekingalpha.com •

                                            • Forget AMC, GameStop: Analyst Names 2 New Reddit Stocks Traders Should Watch
                                              benzinga.com •

                                            • Is BioCryst a Good Stock to Buy Now?
                                              fool.com •

                                            • Is the Options Market Predicting a Spike in BioCryst (BCRX) Stock?
                                              zacks.com •

                                            • Why BioCryst Pharmaceuticals Stock Is Jumping Today
                                              fool.com •

                                            • BioCryst Receives UK Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
                                              globenewswire.com •

                                            • Strength Seen in BioCryst (BCRX): Can Its 21% Jump Turn into More Strength?
                                              zacks.com •

                                            • BioCryst: Solid Delivery And Follow Through
                                              seekingalpha.com •

                                            • BCRX Stock: 24.35% Increase (From $10.68 To $13.28) Intraday Explanation
                                              pulse2.com •

                                            • BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q1 2021 Results - Earnings Call Transcript
                                              seekingalpha.com •

                                            • BioCryst Shares Trading Higher As Q1 Sales Beat Was Supported By Orladeyo Revenues
                                              benzinga.com •

                                            • Why BioCryst Pharmaceuticals Stock Is Soaring Today
                                              fool.com •

                                            • BioCryst Receives European Commission Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
                                              globenewswire.com •

                                            • BioCryst Announces Approval of Japanese NHI Price Listing of ORLADEYO™ (berotralstat) for Prophylactic Treatment of Hereditary Angioedema
                                              globenewswire.com •

                                            • BioCryst to Present at 20th Annual Needham Virtual Healthcare Conference
                                              globenewswire.com •

                                            • BCRX Stock Price: $15 Target By Piper Sandler
                                              pulse2.com •

                                            • BioCryst Technical Levels To Watch
                                              benzinga.com •

                                            • FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings
                                              benzinga.com •

                                            • BioCryst Appoints Helen Thackray, M.D., as Chief Research and Development Officer
                                              globenewswire.com •

                                            • BioCryst, Editas, Groupon, Sunrun, Twitter and More of Monday Afternoon's Analyst Calls
                                              247wallst.com •

                                            • BioCryst's Orladeyo Wins EU Positive Opinion For Hereditary Angioedema
                                              benzinga.com •

                                            Copyright © 2022 finabase.io